β3-integrin regulates vascular endothelial growth factor-A-dependent permeability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 11, 2004, Pages 2108-2114

  Robinson, Stephen D ^a   Reynolds, Louise E ^a   Wyder, Lorenza ^b   Hicklin, Daniel J ^c   Hodivala Dilke, Kairbaan M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

3 integrin; Endothelium; Flk 1; Permeability; VEGF

Indexed keywords

BETA3 INTEGRIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; BLOOD VESSEL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; DRUG ANTAGONISM; INFLAMMATION; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; INFLAMMATION; INTEGRIN BETA3; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 8344265218     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000143857.27408.de     Document Type: Article

References (57)

1. Hynes R. Integrins: versatility, modulation, and signalling in cell adhesion. Cell. 1992;69:11-25.
2. Luscinskas F, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 1994;8:929-938.
3. Hynes R, Bader B, Hodivala-Dilke K. Integrins in vascular development, Braz J Med Biol Res. 1999;32:501-510.
4. Martinez-Lemus LA, Wu X, Wilson E, Hill MA, Davis GE, Davis MJ, Meininger GA. Integrins as unique receptors for vascular control. J Vasc Res. 2003;40:211-233.
5. Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, Hynes RO. Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol. 2002;22:927-933.
6. Madri J, Williams, S. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol. 1983;97:153-165.
7. Form D, Pratt B, Madri J. Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest. 1986;55:521-530.
8. Underwood P, Bennett F. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells. Exp Cell Res. 1993;205:311-319.
9. Tsou R, Isik FF. Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem. 2001;224:81-89.
10. Senger D, Galli S, Dvorak A, Perruzzi C, Harvey V, Dvorak H. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-985.
11. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001;280:C1358-C1366.
12. Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat. 2002;200:581-597.
13. Ruhrberg C. Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays. 2003;25:1052-1060.
14. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci. 2003;28:488-494.
15. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med. 2002;8:27-34.
16. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin D. Anti-VEGF receptor (Flk-1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 1999;59:5209-5218.
17. Hodivala-Dilke K, McHugh K, Tsakiris D, Rayburn H, Crowley D, Ullman-Cullere M, Ross F, Coller B, Teitelbaum S, Hynes R. β3-integrin deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103:229-238.
18. Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol. 1998;153:1099-1112.
19. Wójciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. Rho and Rac, but not Cdc42 regulate endothelial cell permeability. J Cell Sci. 2001; 114:1343-1355.
20. Miles A, Miles E. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol. 1952;118:228-257.
21. Buckley T, Brain S, Williams T. Ruthenium red selectively inhibits oedema formation and increased blood flow induced by capsaicin in rabbit skin. Br J Pharmacol. 1990;99:7-8.
22. 133Xenon clearance technique. J Pharmacol Toxicol Methods. 1994;32:41-47.
23. Baluk P, Thurston G, Murph TJ, Bunnett NW, McDonald DM. Neurogenic plasma leakage in mouse airways. Br J Pharmacol. 1999;126:522-528.
24. Plendl J, Neumuller C, Vollmar A, Auerbach R, Sinowatz F. Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat Embryol (Berl). 1996;194:445-456.
25. Zweifach BW. Microcirculation. Annu Rev Physiol. 1973;35:117-150.
26. Bergman RK, Munoz JJ. Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. J Allergy Clin Immunol. 1975; 55:378-385.
27. Svensjo E, Grega G. Evidence for endothelial cell-mediated regulation of macromolecular permeability by postcapillary venules. Fed Proc. 1986; 45:89-95.
28. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004;5:261-270.
29. Ingber D, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol. 1989;109:317-330.
30. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem. 1991;47:236-241.
31. Klasgsbrun M. Regulators of angiogenesis: stimulators, inhibitors, and extracellular matrix. J Cell Biochem. 1991;47:199-200.
32. Kanda S, Tomasini-Johansson B, Klint P, Dixelius J, Rubin K, Claesson-Welsh L. Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation. Exp Cell Res. 1999;248:203-213.
33. Byzova T, Rabbani R, Souza S, Plow E. Role of integrin αvβ3 in vascular biology. Thromb Haemost. 1998;80:726-734.
34. Friedlander M, Brooks P, Shaffer R, Kincaid C, Varner J, Cheresh D. Definition of two angiogenic pathways by distinct α v integrins. Science. 1995;270:1500-1502.
35. Stromblad S, Cheresh, D. Integrins, angiogenesis and vascular cell survival. Chem Biol. 1996;3:881-885.
36. Eliceiri B, Cheresh D. The role of α v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999; 103:1227-1230.
37. Hodivala-Dilke KM, Reynolds AR, Reynolds LE. Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res. 2003;314:131-144.
38. Brooks P, Montgomery A, Rosenfeld M, Reisfeld R, Hu T, Klier G, Cheresh, D. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
39. Felding-Habermann B, Cheresh D. Vitronectin and its receptors. Curr Opin Cell Biol. 1993;5:864-868.
40. Brassard D, Maxwell E, Malkowski M, Nagabhushan T, Kumar C, Armstrong L. Integrin α(v)β(3)-mediated activation of apoptosis. Exp Cell Res. 1999;251:33-45.
41. Bader B, Rayburn H, Crowley D, Hynes R. Extensive vasculogenesis, angiogenesis and organogenesis precede lethality in mice lacking all αv integrins. Cell. 1998;95:507-519.
42. Huang X, Griffiths M, Wu J, Farese R, Sheppard D. Normal development, wound healing, and adenovirus susceptibility in β5-deficient mice. Mol Cell Biol. 2000;20:755-759.
43. Curtis T, McKeown-Longo P, Vincent P, Homan S, Wheatley E, Saba T. Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-α 5 β 1, or TNF-α exposure. Am J Physiol. 1995;269:L248-L260.
44. Qiao R, Yan W, Lum H, Malik A. Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response. Am J Physiol. 1995;269:C110-C117.
45. Wu M, Ustinova E, Granger H. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J Physiol. 2001;532:785-791.
46. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999;18:882-892.
47. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell. 2000;6:851-860.
48. van Bruggen N, Thibodeaux H, Palmer J, Lee W, Fu L, Cairns B, Tumas D, Gerlai R, Williams S, van Lockeren Campagne M, Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest. 1999;104:1613-1620.
49. The T.E.S. Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF peglyated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina. 2002;22:143-152.
50. Gutheil J, Campbell T, Prierce P, Watkins J, Huse W, Bodkin D, Cheresh D. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3. Clin Cancer Res. 2000;6:3056-3061.
51. Tsukada H, Ying X, Fu C, Ishikawa S, McKeown-Longo P, Albelda S, Bhattacharya S, Anderson Bray B, Bhattacharya J. Ligation of endothelial αvβ3 integrin increases capillary hydraulic conductivity of rat lung. Circ Res. 1995;77:651-659.
52. Mukhopadhyay D, Datta K. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors. Semin Cancer Biol. 2004;14:123-130.
53. Roth T, Podesta F, Stepp M, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA. I993;90:9640-9644.
54. Regoli M, Bendayan M. Alterations in the expression of the α 3 β 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia. 1997;40:15-22.
55. Intengan H, Thibault G, Li J, Schiffrin E. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999;100:2267-2275.
56. Bishop G, McPherson J, Sanders J, Hesselbacher S, Feldman M, McNamara C, Gimple L, Powers E, Mousa S, Sarembock I. Selective α(v)β(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation. 2001;103:1906-1911.
57. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002;62:5381-5385.